MoneyWorks4Me

Granules India informs about quarterly statement on investor complaints

12 Apr 2016 Evaluate

Granules India has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended March 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1847.55
Dr. Reddys Labs. 1193.15
Cipla 1378.70
Lupin 2086.60
Zydus Lifesciences 1154.50
View more..